• Ultrafiltration Enables High-Purity Circular RNA Isolation

  2026-05-20

  Guillen-Cuevas et al. introduce ultrafiltration as a powerful method for purifying circular RNA, significantly outperforming traditional SE-HPLC in both yield and purity. Their findings support ultrafiltration's potential for scalable production of stable circRNA therapeutics.

• Lysis Buffer in Rapid Genotyping: Optimizing Mouse DNA Extra

  2026-05-20

  Unlock rapid, high-integrity genomic DNA release from mouse tissues with the APExBIO lysis buffer—a cornerstone rapid genotyping kit component. This article details evidence-based workflows, advanced troubleshooting, and actionable upgrades for mouse tail genotyping assays in modern genetic research.

• Calpeptin: Potent Calpain Inhibitor for Fibrosis Research

  2026-05-19

  Calpeptin sets a new standard for calpain inhibition, enabling high-precision workflows in fibrosis and inflammation research. Its nanomolar potency, validated selectivity, and versatility in EV studies unlock reproducible, translational insight not achievable with generic inhibitors.

• Alda 1 and ALDH2 Activation: New Mechanistic Insights for Ca

  2026-05-19

  Discover how Alda 1, a potent ALDH2 activator, enables advanced research into cardioprotection and tissue regeneration. This article reveals new mechanistic insights and practical considerations that distinguish it from existing protocols.

• ML385: NRF2 Inhibitor Protocols for Cancer and Oxidative Str

  2026-05-18

  ML385, a selective NRF2 inhibitor from APExBIO, empowers researchers to dissect NRF2-regulated pathways in cancer and oxidative stress models with unmatched precision. This article provides stepwise protocol enhancements, advanced troubleshooting guidance, and actionable insights from recent ferroptosis and ALD research.

• mRNA Encapsulation and Delivery via MOF Nanostructures: Firs

  2026-05-18

  This study pioneers the use of zeolitic imidazole framework-8 (ZIF-8) metal-organic frameworks (MOFs) for the encapsulation, stabilization, and delivery of messenger RNA, achieving effective protein expression after both short- and long-term storage. The work establishes a robust non-viral platform for mRNA transport, with implications for gene therapy, mRNA vaccine technology, and nucleic acid-based therapeutics.

• Firefly Luciferase mRNA (ARCA, 5-moUTP): Precision for Gene

  2026-05-17

  Firefly Luciferase mRNA (ARCA, 5-moUTP) from APExBIO delivers unmatched reproducibility and sensitivity for gene expression, cell viability, and in vivo imaging workflows. Its advanced capping and 5-methoxyuridine modifications reduce immune activation and boost translation, setting a new standard for bioluminescent reporter assays.

• Kanamycin Sulfate: Water-Soluble Antibiotic for Research Pre

  2026-05-16

  Kanamycin Sulfate is a water-soluble antibiotic used extensively in microbiology and antibiotic resistance research. Its high purity and robust protein synthesis inhibition make it ideal for selective cell culture and mechanistic studies. Stringent storage conditions and validated assay parameters ensure reproducibility and reliability.

• BAF53a as a Prognostic and EMT Driver in Glioma Progression

  2026-05-15

  Meng et al. identify BAF53a as a novel prognostic biomarker in glioma, showing that its overexpression correlates with poor patient survival and promotes epithelial-mesenchymal transition (EMT) and invasion in glioma cells. These findings provide mechanistic insight into glioma progression and offer new directions for biomarker-driven therapeutic strategies.

• Isoprinosine: Mechanistic Insights and Strategic Leverage in

  2026-05-15

  This thought-leadership article bridges mechanistic discoveries in herpesvirus nuclear egress, particularly the CLCC1-mediated fusion stage, with translational strategies for leveraging Isoprinosine (inosine pranobex) as a dual-action immunomodulator and antiviral agent. It critically examines how Isoprinosine’s unique mechanism—direct viral inhibition and immune enhancement—offers strategic advantages for researchers navigating assay design, clinical translation, and competitive positioning in the treatment of acute respiratory viral infections. Drawing on recent high-impact studies and workflow guidance, the article differentiates itself by synthesizing mechanistic virology, experimental protocols, and evidence-backed translational recommendations.

• Caffeic Acid Phenethyl Ester as a Novel Inhibitor of C. diff

  2026-05-14

  Guo et al. (2025) identify caffeic acid phenethyl ester (CAPE) as a direct inhibitor of the TcdB toxin in Clostridioides difficile, demonstrating both toxin neutralization and microbiota modulation in a murine infection model. This study advances therapeutic strategies for antibiotic-associated C. difficile infections by targeting virulence rather than relying solely on conventional antibiotics.

• Indomethacin for Inflammation and Lipid Metabolism Research

  2026-05-14

  Leverage Indomethacin’s Cox-1 selectivity and PPARγ agonism to interrogate inflammation, adipocyte differentiation, and membrane signaling in advanced metabolic studies. APExBIO’s formulation ensures batch consistency and solubility, streamlining workflows for both in vitro and in vivo research.

• DM-β-CD Complexation Increases Mianserin HCl Cytotoxicity In

  2026-05-13

  This study rigorously investigates the interaction between mianserin hydrochloride (Mianserin HCl) and heptakis (2,6-di-O-methyl)-β-cyclodextrin (DM-β-CD), focusing on the binding mechanism and its impact on cytotoxicity. Contrary to expectations from prior β-cyclodextrin complexation studies, the DM-β-CD inclusion complex with Mianserin HCl increased, rather than reduced, cytotoxicity in cell assays—a finding with significant implications for the design of antidepressant research compounds and drug delivery systems.

• HyperScribe All in One mRNA Synthesis Kit: Precision for Vac

  2026-05-13

  The HyperScribe All in One mRNA Synthesis Kit streamlines ARCA-capped, polyadenylated mRNA production for advanced immunotherapy and translational research. Its workflow ensures high-yield, translationally competent mRNA, making it ideal for mRNA vaccine synthesis and RNA-based functional studies.

• Miltefosine Induces Neutrophil Differentiation via Ras/MEK/E

  2026-05-12

  This study demonstrates that Miltefosine (hexadecyl 2-(trimethylazaniumyl)ethyl phosphate) activates the Ras/MEK/ERK pathway to promote neutrophil differentiation and restore white blood cell counts in irradiation-induced leukopenia models. The work provides mechanistic insights with translational potential for hematological recovery in immunocompromised and oncology settings.

15938 records 1/1063 page Next 12345 下5页 Last page